| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.5M | -34.3% |
| Cost of Revenue | $15.6M | -10.1% |
| Gross Profit | $11.9M | -51.4% |
| R&D Expense | $7.8M | +84.5% |
| SG&A Expense | $7.9M | +10.2% |
| Operating Income | -$10.3M | -227.4% |
| Pre-tax Income | -$9.6M | -206.7% |
| Income Tax | -$1.9M | -180.2% |
| Net Income | -$7.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.1M | +0.1% |
| Accounts Receivable | $6.0M | -69.4% |
| Inventory | $14.6M | +44.2% |
| Current Assets | $45.9M | -19.1% |
| Total Assets | $53.0M | -14.7% |
| Current Liabilities | $4.7M | -19.8% |
| Total Liabilities | $4.9M | -22.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $528K | +163.5% |
| Capital Expenditures | $196K | -29.0% |
| Investing Cash Flow | -$196K | +29.0% |
| Financing Cash Flow | -$305K | -2133.3% |
| Free Cash Flow | $332K | +130.0% |
| -216.1% |
| EPS (Basic) | -$0.47 | -214.6% |
| EPS (Diluted) | -$0.47 | -214.6% |
| Stockholders' Equity |
| $48.1M |
| -13.8% |